Found: 9
Select item for more details and to access through your institution.
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-33352-3
- By:
- Publication type:
- Article
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
- Published in:
- Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-022-01033-9
- By:
- Publication type:
- Article
Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 4, p. 519, doi. 10.3390/biom10040519
- By:
- Publication type:
- Article
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 4, p. 339, doi. 10.1111/ejh.12176
- By:
- Publication type:
- Article
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 5, p. 354, doi. 10.1111/j.1600-0609.2009.01225.x
- By:
- Publication type:
- Article
Caspase-8 regulates the expression of pro- and anti-inflammatory cytokines in human bone marrow-derived mesenchymal stromal cells.
- Published in:
- Immunity, Inflammation & Disease, 2016, v. 4, n. 3, p. 327, doi. 10.1002/iid3.117
- By:
- Publication type:
- Article
Toll-like receptor signaling in multiple myeloma cells promotes the expression of prosurvival genes B-cell lymphoma 2 and MYC and modulates the expression of B-cell maturation antigen.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1393906
- By:
- Publication type:
- Article
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
- Published in:
- Cell Communication & Signaling, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12964-015-0104-z
- By:
- Publication type:
- Article
Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone.
- Published in:
- JBMR Plus, 2020, v. 4, n. 1, p. 1, doi. 10.1002/jbm4.10247
- By:
- Publication type:
- Article